天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Inhibitors>Brigatinib
Brigatinib
  • Brigatinib

Brigatinib NEW

Price Get Latest Price
Package 1kg 5kg 25kg
Min. Order: 1kg
Supply Ability: 10000
Update Time: 2024-12-23

Product Details

Product Name: Brigatinib CAS No.: 1197953-54-0
Min. Order: 1kg Purity: 99.0%
Supply Ability: 10000 Release date: 2024/12/23

Brigatinib, a second-generation ALK inhibitor, is the preferred choice after resistance to crizotinib. Similar to ceritinib, it targets ALK, ROS1, and Met amplifications. For patients with ALK-mutated non-small cell lung cancer who have developed resistance to crizotinib, Brigatinib can be considered as an alternative treatment option. Clinical trials have demonstrated that Brigatinib can significantly prolong the median progression-free survival (PFS) to 13.9 months, making it the only anticancer drug currently available that extends PFS by over one year for patients resistant to crizotinib."

This product is for research purposes only. If  above  product   has  patent protection in your market , their price quoted will be invalid , and  all relevant  commerical actives must be stopped!


Company Profile Introduction

Enki Biopharmaceuticals (shanghai) Limited. is a cutting-edge pharmaceutical company committed to the comprehensive exploration, development, manufacturing, and commercialization of top-tier pharmaceutical products. The company established its state-of-the-art technology research and development center in Suzhou City, Jiangsu Province in 2016 and possesses production facilities located in Sichuan Province and Hunan Province. Enki Biopharma is propelled by technological research and development, with a primary focus on the R&D and production of high value-added and high-tech pharmaceutical intermediates/chiral compounds. The ultimate objective is to achieve industrialization through the creation of active pharmaceutical ingredients (APIs), while concurrently establishing core competencies in chiral synthesis, chemical/enzymatic catalysis, and clean production processes. The products primarily target premium foreign markets while simultaneously serving as intermediate support for domestic API production. Enki Biopharma embraces a market-oriented business philosophy, with innovation support and industrialization as its ultimate goals. It upholds the corporate spirit of focus, expertise, innovation, and win-win situations while remaining committed to the mission of creating value for customers, providing opportunities for employees, and promoting human health. Our utmost dedication lies in delivering high-quality products and premium services to our esteemed customers in order to achieve mutual success together. Simultaneously, we strive to foster employee development and promote social harmony.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/100g
VIP1Y
Cangzhou Kangrui Pharma Tech Co. Ltd.,
2024-10-18
$0.00/1g
VIP1Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2024-08-02
$0.00/1kg
VIP1Y
Shaanxi TNJONE Pharmaceutical Co., Ltd
2024-05-13
$0.00/1kg
VIP5Y
Hebei Yanxi Chemical Co., Ltd.
2023-10-09
$0.00/25kg
Shaanxi Haibo Biotechnology Co., Ltd
2023-09-05
$100.00/25kg
VIP5Y
Hebei Mojin Biotechnology Co., Ltd
2022-07-04
$0.00/10mg g kg
VIP3Y
Zhengzhou Anhuida Chemical Co., Ltd
2022-07-02
$15.00/1g
Qiuxian Baitai New Material Co., LTD
2021-11-03
$1.10/1g
VIP4Y
Dideu Industries Group Limited
2021-08-17
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-10
  • Since: 2014-09-10
  • Address: Room 708, Building B(No. 2), No.125 Laiting South Road, Songjiang District, Shanghai,China
INQUIRY